GlycanAge

United Kingdom
Newcastle upon Tyne, England, United Kingdom, NE4 5TG

Company profile

GlycanAge company profile

GlycanAge stands at the forefront of the health-tech and longevity sectors, boasting a technology forged from over three decades of rigorous research and analysis of 200,000 testing samples. Utilizing the largest proprietary dataset of human glycome, GlycanAge is pioneering advanced blood biomarkers for the prediction of age-related diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-01-15

Headquarters

Postal code
NE4 5TG
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
6
Total equity funding
$14M
Last funding
Series Unknown / $8.7M / 2025-12-18
Last equity funding
Series Unknown / $8.7M
Investors
17
Lead investors
5
Founders
2
Articles
193

Founders and investors

Founders

Gordan LaucNikolina Lauc

Lead investors

Fifth Quarter VenturesHub71Impulse GrowthKadmos CapitalLAUNCHub Ventures

Investors

BrightCap VenturesExceptional VenturesLAUNCHub VenturesPareto HoldingsSouth Central Ventures